Clinical trials recruiting for Idiopathic Inflammatory Myopathies (IIMs)
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Allogeneic NK Cells | 1 |
| Dengue 1,2,3,4 (attenuated) vaccine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Montana | 1 |
| North Carolina | 1 |
| South Carolina | 1 |
| Tennessee | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Related conditions
Trials recruiting for Idiopathic Inflammatory Myopathies (IIMs) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Idiopathic Inflammatory Myopathies (IIMs) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.